Clinical Trial: Carbon Monoxide Measurement to Screen for Sickle Cell Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Point-of-Care End-Tidal Carbon Monoxide Measurement to Screen for Sickle Cell Disease

Brief Summary: Modify the design of the CoSense device (Model C20112, currently cleared by the FDA for ETCO (end-tidal carbon monoxide) monitoring to improve accuracy and consistency under temperature conditions encountered in countries with high prevalence of SCD (Sickle Cell Disease).